SOURCE: Endo Pharmaceuticals

August 11, 2008 12:00 ET

Endo Pharmaceuticals Appoints Dr. Sandeep Gupta, Senior Vice President, Discovery and Early Development

CHADDS FORD, PA--(Marketwire - August 11, 2008) - Endo Pharmaceuticals (NASDAQ: ENDP) announced today that Dr. Sandeep Gupta has been appointed Senior Vice President, Discovery and Early Development. He will report to Executive Vice President, Research & Development, Dr. Ivan Gergel.

"We are excited that Sandeep Gupta has decided to join the Endo Research and Development team," said Dr. Gergel. "Sandeep's broad range of expertise in the pre-clinical space, including drug discovery and pharmacology, and the scientific evaluation of in-licensing opportunities, is closely aligned with the experience we need as we look to enhance the core competencies in our R&D organization."

Prior to joining Endo, Dr. Gupta served as head of drug discovery and pharmacology at Forest Laboratories. Dr. Gupta joined Forest in 1998 after nearly a decade in academia, including faculty positions at the University of Pennsylvania's Department of Surgery and the Boston University School of Medicine.

Dr. Gupta graduated with a BS in Pharmacy from Banaras Hindu University in India in 1982 and earned his Doctorate in Pharmacology from Northeastern University in 1989. He is a member of the American Diabetes Association, the European Association for the Study of Diabetes and the American Urological Association.

About Endo

Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available at

Contact Information

    Blaine Davis
    (610) 459-7158